NCT02545504 Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Status COMPLETED Phase PHASE3
NCT02538614 Study of Idelalisib in Combination With BI 836826 in Participants With Chronic Lymphocytic Leukemia Status TERMINATED Phase PHASE1
NCT02537379 Use-Results Surveillance Study of Sovaldi® Plus Copegus® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection Status COMPLETED Phase N/A
NCT02536313 Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination With or Without Ribavirin in Participants With Chronic Genotype 1 HCV Infection Previously Treated With a Direct Acting Antiviral Regimen Status COMPLETED Phase PHASE2
NCT02536300 Dose Optimization Study of Idelalisib in Follicular Lymphoma Status TERMINATED Phase PHASE3
NCT02534350 Presatovir in Lung Transplant (LT) Recipients With Respiratory Syncytial Virus (RSV) Infection Status COMPLETED Phase PHASE2
NCT02533544 Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B Status COMPLETED Phase N/A
NCT02533427 Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol Status COMPLETED Phase PHASE1
NCT02529059 SSAT058: Atripla to Eviplera Switch in Patients Without Central Nervous System Symptoms Status COMPLETED Phase PHASE4
NCT02521376 Pharmacokinetics of Entospletinib in Adults With Normal and Impaired Liver Function Status COMPLETED Phase PHASE1
NCT02520284 Safety and Efficacy of Andecaliximab (GS-5745) in Adults With Moderately to Severely Active Ulcerative Colitis Status TERMINATED Phase PHASE2/PHASE3
NCT02510300 A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials Status TERMINATED Phase N/A
NCT02509624 Study to Evaluate the Pharmacokinetics of Selonsertib in Participants With Normal and Impaired Hepatic Function Status COMPLETED Phase PHASE1
NCT02487030 Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination, With or Without Ribavirin, in Egyptian Adults With Chronic Genotype 4 HCV Infection Status COMPLETED Phase PHASE3
NCT02480712 Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection Status COMPLETED Phase PHASE3
NCT02480166 Comparative Efficacy of Fixed-dose Combination Sofosbuvir + Ledipasvir, 8 vs. 12 Weeks in Chronic Hepatitis C Genotype 6 Status COMPLETED Phase PHASE4
NCT02479880 Utilization and Efficacy of Tenofovir DF in Adolescents With Chronic Hepatitis B Virus Infection Status TERMINATED Phase PHASE4
NCT02477527 Atripla to Stribild Switch Study to Evaluate Sleep Disturbances Status COMPLETED Phase PHASE4
NCT02472886 Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection Status COMPLETED Phase PHASE3
NCT02472535 Study to Evaluate the Effects of MBX-8025 in Patients With HoFH Status COMPLETED Phase PHASE2